New FDA-Approved Triple-Drug-Regimen for Re-Treatment of Hep C | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Hepatitis C Meds Impact Liver Transplant Outlook

Back to News Homepage
Next

FDA Approves 1st Treatment of 8 Weeks Duration for All HCV Genotypes

New FDA-Approved Triple-Drug-Regimen for Re-Treatment of Hep C

The Editors at Hepatitis Central
July 20, 2017

Print this page

Learn more about Gilead’s Vosevi for the re-treatment of Hepatitis C.
Pin it on Pinterest

FDA Approves Gilead’s Vosevi for Re-treatment of Hepatitis C

The Food and Drug Administration (FDA) has approved 12 weeks of Gilead Sciences’ Vosevi (sofosbuvir/velpatasvir/voxilaprevir) for the re-treatment of adults with all genotypes of hepatitis C virus (HCV) who do not have cirrhosis or who have compensated cirrhosis (the milder form of the severe liver disease).

More specifically, the approval is for a second hep C treatment for those with genotypes 1, 2, 3, 4, 5 or 6 who were previously treated with an HCV regimen containing a direct-acting antiviral (DAA) from the NS5A inhibitor class or for those with genotype 1a or 3 who were previously treated with a Sovaldi (sofosbuvir)-containing regimen that did not include an NS5A inhibitor.

Continue reading this entire article:
https://www.hepmag.com/article/fda-approves-gileads-vosevi-retreatment-hepatitis-c

For more information about Vosevi visit https://www.hepatitiscentral.com/vosevi-sofosbuvir-velpatasvir-and-voxilaprevir/what-is-vosevi/.

9 Comments
Share
Share
Previous

Hepatitis C Meds Impact Liver Transplant Outlook

Back to News Homepage
Next

FDA Approves 1st Treatment of 8 Weeks Duration for All HCV Genotypes

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.

9 Comments

  • Narinder Saini says:

    From where i will take the treatment in Punjab pin code. 146001 ( India )

    • Narinder Saini says:

      I want to retreat Hep-C.

      Last time i m clear the SVR process and get a certificate.
      Still positive may be disease growing

  • Nana says:

    Now they need to find a cure for hepatitis B

    • Tony Nobaloney says:

      Big pharma is not going to make the kind of profits from a cure as they will from the rip off prices of treatment and re-treatment pills.

  • Sohail Anjum says:

    Now this is Available in Market?

  • anne erdman says:

    I had all those symptoms , fatigue, heart palps, dizziness, vertigo, memory loss , mild random chest pains, with treatment of Harvoni, I would not report, while on Harvoni, as I was dead if I did and dead if I didn’t take Harvoni risk… I was stage 3-4 in 2010, but after 7yrs of holistic changes I was a stage 2-3 that NO doctor would admit to or credit diet and supplements especially “Milk Thistle”….I am now 2+yrs recovered (thank you God) and still have re-accurring symptoms and struggle more than other times randomly with side effects , that are not credited to this whole disease and process of medication….I am alive and grateful

  • Dennis Cyr says:

    Is there A retreatment if you have cirrhosis does anybody know

  • nicki says:

    Last time I heard treatment for Hep C was over 5 grand & very few ins paid for it. I was a guinea pig for new experimental drug back in 1999, then with a different set of drugs in 2000, 2001 & 2003. Last study I had to wait a year to get healthy again. Sid effects were horrid. BUT after all the yrs of treatment, Ive been Neg for Hep C for 13-14 yrs & I had Geno type A1 the hardest to “cure”. I had a Great Dr that never gave up on me.

Leave a Reply

Your email address will not be published. Required fields are marked *